Results for streptogramins translation from English to Maltese

pharmacotherapeutic group: macrolides, lincosamides and streptogramins, atc code:
kategorija farmakoterapewtika: makrolidi, linkosamidi u streptogramini, kodiċi atc:

this is often referred to as mlsb resistance as it affects macrolides, lincosamides and streptogramins.
din ta’ sikwit hija msejħa resistenza mls peress li taffettwa l-makrolidi, il-linkosamidi u l- isteptogramini.

5.1 pharmacodynamic properties lon pharmacotherapeutic group: macrolides, lincosamides and streptogramins, atc code:
riz kategorija farmakoterapewtika: makrolidi, linkosamidi u streptogramini, kodiċi atc:

generally, cross-resistance between tildipirosin and other macrolides, lincosamides or streptogramins is to be expected.
Ġeneralment, cross-resistance bejn tildipirosin u makrolajds oħra, licosamides jew streprogramins hija mistennija.

pharmacotherapeutic group: antibacterials for systemic use, macrolides, lincosamides and streptogramins, atc code: j01fa15.
kategorija farmakoterapewtika: antibijotiċi għal użu sistemiku, makrolidi, linkosamidi u streptogramini, kodiċi atc: j01fa15.

whereas that could make it necessary to use streptogramins as therapeutic agents of last resort to treat germs which have developed resistance to other antibiotics;
billi dan jista' jagħmilha meħtieġ illi jintużaw l-istreptogramini bħala aġenti terapewtiċi ta' l-aħħar rimedju biex jiġu ttrattati l-mikrobi li jkunu żviluppaw resistenza għal antibijotiċi oħra;

whereas it stresses that there is currently no need for streptogramins in denmark as the existing therapeutic treatments for treating enterococci and staphylococci infections are still effective there;
billi l-kumitat jisħaq illi korrentement ma hemm l-ebda ħtieġa ta' l-istreptogramini fid-danimarka billi t-trattamenti terapewtiċi eżistenti għat-trattament ta' l-infezzjonijiet mill-enterokoċċi u l-istafilokoċċi għadhom hemmhekk effettivi;

whereas two streptogramins are clinically important in human medicine in the treatment of last resort of vancomycin resistant enterococci, namely pristinamycin and the combination dalfopristin/quinupristin;
billi żewġ streptogramini huma klinikament importanti fil-mediċina umana fit-trattament ta' l-espedjent aħħari ta' l-enterokoċċi reżistenti għall-vankomiċin, jiġifieri l-pristinamiċin u l-kombinazzjoni dalfopristin/kwinupristin;

this non-target specific efflux mechanism has also been demonstrated to reduce the in vitro activity of streptogramin a.
dan il-mekkaniżmu effluss mhux speċifiku wera wkoll li jnaqqas l-attivita` in vitro ta’ streptogramin a.